Cary Street Partners Financial LLC Astrazeneca PLC Transaction History
Cary Street Partners Financial LLC
- $3.16 Trillion
- Q1 2025
A detailed history of Cary Street Partners Financial LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Cary Street Partners Financial LLC holds 6,306 shares of AZN stock, worth $439,402. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,306
Previous 6,718
6.13%
Holding current value
$439,402
Previous $440 Million
5.3%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,427Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$3.98 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.83 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.48 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.22 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.18 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $216B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...